7.00

1.62% -0.115

After Hours: 6.90 -0.10 -1.43%

Profound Medical Corp (PROF)

Overview News Price History Option Chain Discussions Forecast Stock Split

Profound Medical Corp stock is traded at $7.00, with a volume of 52,549. It is down -1.62% in the last 24 hours and up +11.29% over the past month. Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Previous Close:

$7.115

Open:

$7.3

24h Volume:

52,549

Relative Volume:

0.59

Market Cap:

$210.28M

Revenue:

$8.98M

Net Income/Loss:

$-31.39M

P/E Ratio:

-5.2239

EPS:

-1.34

Net Cash Flow:

$-24.83M

1W Performance:

-3.98%

1M Performance:

+11.29%

6M Performance:

-9.33%

1Y Performance:

-16.17%

1-Day Range:

$6.8637

$7.30

1-Week Range:

$6.37

$7.41

52-Week Range:

$5.63

$11.42

Profound Medical Corp Stock (PROF) Company Profile

Name

Profound Medical Corp

Sector

Healthcare (1169)

Industry

Medical Devices (159)

Phone

647-476-1350

Address

2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON

Employee

142

Twitter

@profoundmedical

Next Earnings Date

2024-11-07

Latest SEC Filings

PROF's Discussions on Twitter

Compare PROF with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PROF Profound Medical Corp	7.00	210.28M	8.98M	-31.39M	-24.83M	-1.34
ABT Abbott Laboratories	129.89	225.27B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.37	140.74B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	363.66	138.77B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	92.33	118.39B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	67.95	39.95B	5.72B	4.17B	259.90M	6.97

Profound Medical Corp Stock (PROF) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-23-24	Initiated	Lake Street	Buy
Jul-16-24	Upgrade	Stifel	Hold → Buy
Nov-28-23	Initiated	Stifel	Hold
Aug-04-23	Downgrade	Raymond James	Strong Buy → Outperform
Mar-21-23	Downgrade	Jefferies	Buy → Hold
Sep-15-20	Initiated	Jefferies	Buy

View All

Profound Medical Corp Stock (PROF) Latest News

Mar 12, 2025

Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - Business Wire

Mar 12, 2025

How To Trade (PROF) - Stock Traders Daily

Mar 12, 2025

Mar 11, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp.PROF - PR Newswire

Mar 11, 2025

Mar 10, 2025

(PRN) Dynamic Trading Report (PRN:CA) - Stock Traders Daily

Mar 10, 2025

Profound Medical revises financials, corrects revenue overstatement By Investing.com - Investing.com South Africa

Mar 10, 2025

Profound Medical Corp. (NASDAQ:PROF) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 10, 2025

Profound Medical revises financials, corrects revenue overstatement - Investing.com

Mar 10, 2025

Mar 08, 2025

Profound Medical Q4 2024 revenue jumps 108% to USD 4.2M - Medical Buyer

Mar 08, 2025

Mar 07, 2025

Stifel maintains Buy on Profound Medical, $12 target post-Q4 results - Investing.com Canada

Mar 07, 2025